MicroRNA Dysregulation in Colorectal Cancer
Author Information
Author(s): Dong Y, Wu W K K, Wu C W, Sung J J Y, Yu J, Ng S S M
Primary Institution: The Chinese University of Hong Kong
Hypothesis
The study investigates the potential utility of microRNAs (miRNAs) as biomarkers for colorectal cancer (CRC) diagnosis, prognosis, and susceptibility.
Conclusion
The use of miRNAs as biomarkers for CRC is still in its infancy and needs further characterization and evaluation.
Supporting Evidence
- Approximately 1.23 million individuals worldwide will develop CRC and 0.6 million people will die of it annually.
- Circulating miRNAs can potentially serve as noninvasive markers for CRC detection.
- Stool miRNA testing has the advantage for pre-cancerous lesion screening.
Takeaway
Scientists are looking at tiny molecules called microRNAs to help find and understand colorectal cancer better.
Methodology
The review summarizes recent findings on the role of miRNAs in CRC and discusses their potential as diagnostic and prognostic markers.
Limitations
The study highlights that many miRNAs discussed have not progressed beyond the preclinical stage and require further validation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website